An interventional study of Virtual reality and Standard of care in Anxiety, sponsored by Mohammed Bin Rashid University of Medicine and Health Sciences. Not yet recruiting. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-07-02.
Sponsored by Mohammed Bin Rashid University of Medicine and Health Sciences · Not applicable, Interventional, and Supportive care
This study examines the effectiveness of virtual reality (VR) protocols based on mindfulness as a nonpharmacological approach to reduce social anxiety among adolescents. Conducted as a non-randomized, controlled, multi-center trial, the research aims to provide evidence supporting the integration of VR mindfulness interventions into clinical practice to improve mental health and well-being among adolescents. The research focuses on adolescent patients aged 12 to 18 who present with anxiety-related symptoms. Each participant will undergo a single primary care consultation, during which they will experience a 15-20 minute VR session using the Healthy Mind® platform both before and after their clinical encounter. Participants will be screened with the Generalized Anxiety Disorder 7 (GAD-7) scale. To measure changes in anxiety levels, the State-Trait Anxiety Inventory (STAI) will be administered immediately before and after the VR sessions. This setup aims to assess the immediate impact of immersive VR on perceived anxiety in a real-world outpatient environment.
7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.
This study's planned enrollment of 50 is below the median of 80 across 6,057 interventional studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →Mohammed Bin Rashid University of Medicine and Health Sciences is the lead sponsor of 20 studies on the registry; 11 are open to participants now.
Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Each participant will attend a single primary care clinic visit during which they will undergo the VR intervention. Before the VR session is conducted, participants will be screened using the Generalized Anxiety Disorder 7-item scale (GAD-7). If the GAD-7 score is more than 5, a 20-minute VR session will be administered before the consultation. Anxiety levels will be measured using State Trait Anxiety Inventory for Adolescents (STAI-A) \[24\] and the Visual Analog Scale (VAS) both before the initial VR session and after the consultation. This pre-post assessment will allow for the evaluation of immediate changes in social anxiety resulting from the VR experience within a real-world clinical setting
Other: Virtual reality
Patients receiving standard of care. In the current clinical setting, adolescent patients attending primary care visits do not receive any structured mental health support or targeted anxiety-reduction strategies as part of routine care. Patients typically wait in the general clinic waiting area prior to their consultation, accompanied by their legal guardian.
Other: Standard of care
Participants will be instructed to engage in a virtual reality relaxation session lasting 20 minutes as part of their primary care visit. The intervention will use the Healthy Mind® virtual reality platform (developed in Paris, France) delivered through virtual reality headsets. Participants will be able to choose from a variety of immersive environments (e.g., beach, lake, mountain), each incorporating animated visuals, soothing audio, and guided breathing exercises. These VR scenarios are grounded in psychological relaxation principles such as cardiac coherence, hypnotic verbal accompaniment, and mindfulness-based stress reduction.
Adolescent patients attending primary care visits do not receive any structured mental health support or targeted anxiety-reduction strategies as part of routine care prior to their appointments.
State Trait Anxiety Inventory for Adolescents (STAI-A) Score
Minimum score: 20 (Least anxiety). Maximum score: 80 (Highest anxiety)
Time frame: Baseline and immediately post intervention
Visual Analog Scale (VAS)
Minimum score: 0 (No anxiety), Maximum score: 10 (Highest anxiety)
Time frame: Baseline and immediately post intervention
Generalized Anxiety Disorder - 7 Score
Minimum score: 0 (Minimal Anxiety), Maximum score: 21 (Severe anxiety)
Time frame: Baseline and immediately post-intervention
No study locations are listed for this record.
Start is estimated for Jun 2026; primary completion for Aug 2026, 2 months later.
Of 3,836 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 2 months is below that.
Counting every sponsor, half of 3,938 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mohammed Bin Rashid University of Medicine and Health Sciences